HK1209112A1 - Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide - Google Patents

Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide Download PDF

Info

Publication number
HK1209112A1
HK1209112A1 HK15109782.6A HK15109782A HK1209112A1 HK 1209112 A1 HK1209112 A1 HK 1209112A1 HK 15109782 A HK15109782 A HK 15109782A HK 1209112 A1 HK1209112 A1 HK 1209112A1
Authority
HK
Hong Kong
Prior art keywords
tetralactam
macrocycles
anthracenyl
detecting
target saccharide
Prior art date
Application number
HK15109782.6A
Other languages
English (en)
Chinese (zh)
Inventor
Chenfeng Ke
Anthony P Davis
Original Assignee
University Of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Bristol filed Critical University Of Bristol
Publication of HK1209112A1 publication Critical patent/HK1209112A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK15109782.6A 2012-04-27 2013-04-26 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide HK1209112A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1207392.0 2012-04-27
GBGB1207392.0A GB201207392D0 (en) 2012-04-27 2012-04-27 Novel compounds
PCT/GB2013/051079 WO2013160701A1 (en) 2012-04-27 2013-04-26 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide

Publications (1)

Publication Number Publication Date
HK1209112A1 true HK1209112A1 (en) 2016-03-24

Family

ID=46330449

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109782.6A HK1209112A1 (en) 2012-04-27 2013-04-26 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide

Country Status (9)

Country Link
US (2) US9610365B2 (enExample)
EP (1) EP2855439B1 (enExample)
CN (1) CN104428290B (enExample)
AU (1) AU2013254450A1 (enExample)
CA (1) CA2910581A1 (enExample)
GB (2) GB201207392D0 (enExample)
HK (1) HK1209112A1 (enExample)
IN (1) IN2014DN09830A (enExample)
WO (1) WO2013160701A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201207392D0 (en) 2012-04-27 2012-06-13 Univ Bristol Novel compounds
WO2018167503A1 (en) * 2017-03-15 2018-09-20 Ziylo Limited Macrocyclic compounds
WO2020058322A1 (en) * 2018-09-19 2020-03-26 Ziylo Ltd. Glucose sensitive insulins and uses thereof
PL4003165T3 (pl) * 2019-07-30 2024-06-10 Emd Millipore Corporation Sposób syntezy związków chemicznych
RU2752711C2 (ru) * 2019-11-18 2021-07-30 Общество с ограниченной ответственностью «Лаборатория межклеточных технологий «Интерсел Рэнд» (ООО «Интерсел Рэнд») Способ и устройство для спектроскопии живой ткани
KR20230127067A (ko) * 2022-02-24 2023-08-31 삼성에스디아이 주식회사 코어-쉘 염료, 이를 포함하는 근적외선 흡수성 수지 조성물 및 근적외선 흡수 필름

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6815901A (en) * 2000-06-02 2001-12-17 Zycos Inc Delivery systems for bioactive agents
JP2003073399A (ja) * 2001-08-31 2003-03-12 Japan Science & Technology Corp 発蛍光性修飾タンパク質
US7179616B1 (en) 2002-10-07 2007-02-20 University Of Notre Dame Du Lac Method for detecting phosphatidylserine on the surface of cells
US8642014B2 (en) * 2007-01-30 2014-02-04 Seta Biomedicals, Llc Luminescent compounds
WO2011059457A1 (en) * 2009-11-16 2011-05-19 University Of Notre Dame Du Lac High performance luminescent compounds
WO2011087521A1 (en) * 2010-01-13 2011-07-21 University Of Notre Dame Du Lac Chemiluminescent dyes and dye-stained particles
GB201207392D0 (en) 2012-04-27 2012-06-13 Univ Bristol Novel compounds

Also Published As

Publication number Publication date
GB2517345A (en) 2015-02-18
CN104428290B (zh) 2017-11-14
US20150147275A1 (en) 2015-05-28
US9610365B2 (en) 2017-04-04
AU2013254450A1 (en) 2014-11-27
US9937272B2 (en) 2018-04-10
GB201420937D0 (en) 2015-01-07
GB201207392D0 (en) 2012-06-13
WO2013160701A1 (en) 2013-10-31
CN104428290A (zh) 2015-03-18
IN2014DN09830A (enExample) 2015-08-07
EP2855439B1 (en) 2017-06-14
US20170266321A1 (en) 2017-09-21
CA2910581A1 (en) 2013-10-31
EP2855439A1 (en) 2015-04-08

Similar Documents

Publication Publication Date Title
WO2014089209A3 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins
WO2009009756A3 (en) Polyviologen boronic acid quenchers for use in analyte sensors
WO2012088290A3 (en) Tri-variable domain binding proteins and uses thereof
EP2593159B8 (en) I.v. infusion or blood collection apparatus
WO2011089183A3 (en) Anticoagulant antidotes
WO2013039477A8 (en) Non-invasive methods of detecting target molecules
WO2013036543A3 (en) Molecular imaging of cancer cells in vivo
WO2012018790A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2012061558A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2012027570A3 (en) Dual variable domain immunoglobulins and uses thereof
HK1199100A1 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2014144280A8 (en) DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1β AND / OR IL-17
HK1209112A1 (en) Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide
WO2012158780A3 (en) Lung cancer signature
EP2600761A4 (en) MEMBRANE COMPOSITION FOR BIOSENSOR, BIOSENSOR AND METHODS OF MAKING THE SAME
WO2010108173A3 (en) Endotracheal tube with sensors
WO2014106001A3 (en) Dual specific binding proteins having a receptor sequence
WO2012012704A3 (en) Methods of detecting kidney-associated diseases or conditions
EP3030891A4 (en) Swcnt biosensor for detecting glucose, lactate, and urea
ZA201402745B (en) Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and the use thereof.
HK1212734A1 (zh) 用於检测创伤後应激障碍(ptsd)的标志物和方法
WO2012135432A3 (en) Dyes for membranes and biological structures
WO2014096973A3 (en) Systems and methods for internal analyte sensing
WO2008122088A8 (en) Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex